Follow the 4Front Ventures Corp. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, 4Front Ventures Corp. has recorded 26 insider filings. Market capitalisation: €9k. The latest transaction was reported on 22 April 2025 (Attribution). Among the most active insiders: GULATI CHETAN. The full history is accessible without an account.
26
Insider Decl.
n/a
Thresholds
€1,668
5 ops.
Buy Volume
€4,796
4 ops.
Sell Volume
36Σ signal
Buys €1,668€4,796 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
154,038 sharesClass A Subordinate Voting SharesSEC:0000899243-22-021321:1
Canonical exit: 12 Jul 2022 (T+90)
25 of 26 declarations
Acerca de 4Front Ventures Corp.
4Front Ventures Corp. es una empresa del sector de la salud y farmacéutico, enfocada en el desarrollo y distribución de productos relacionados con el cannabis. Cotiza en NASDAQ bajo el símbolo XNAS.